Cancer Prevention News and Research

RSS

New guidance recommends systematic use of 'exercise prescription' for cancer patients

A global panel of exercise oncology experts today published new guidance recommending the systematic use of an “exercise prescription” to help cancer patients cope with treatment side effects and lower the risk of developing certain cancers.

15 Oct 2019

NCI awards $1.87 million grant to help patients navigate costs of cancer care

The National Cancer Institute has awarded a four-year, more than $1.87 million grant to University of North Carolina Lineberger Comprehensive Cancer Center researchers to study the impact of implementing financial navigation services at five rural cancer centers in North Carolina to help patients cope with the financial burden, or financial toxicity, related to cancer care.

14 Oct 2019

Study reveals link between alterations in RNA splicing and Alzheimer's disease

A collaborative study published today in the journal Cell Reports provides evidence for a new molecular cause for neurodegeneration in Alzheimer's disease.

8 Oct 2019

SunSmart program may have reduced skin cancer rates among younger Australians

A skin cancer prevention program called SunSmart may have contributed to a recent reduction in melanoma among younger residents of Melbourne, according to a study published October 8 in the open-access journal PLOS Medicine by Suzanne Dobbinson of Cancer Council Victoria in Australia, and colleagues.

From PLOS ONE 8 Oct 2019

Multi-gene testing at point of diagnosis can save all women with breast cancer

A lifetime model evaluating the financial, health and social impact of multi-gene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.

3 Oct 2019

CU Anschutz receives NIH Center grant to advance implementation science and cancer control

Drs. Russell Glasgow, Cathy Bradly and colleagues at the Adult and Child Consortium for Health Outcomes and Delivery Science at the University of Colorado Anschutz Medical Campus in Aurora, Colorado have received an NIH Center grant from the National Cancer Institute to advance implementation science and cancer control (1P50CA244688-01).

3 Oct 2019

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University's Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop a universal vaccine to prevent cancer.

2 Oct 2019

New imaging technology may help surgeons better detect cancer during surgery

University of Texas at Dallas researchers have demonstrated that imaging technology used to map the universe shows promise for more accurately and quickly identifying cancer cells in the operating room.

30 Sep 2019

Higher levels of genetic mutations linked to improved outcomes in lung cancer patients

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).

27 Sep 2019

Rice chemist explores how extra amino acid could be used to make life-saving substances

There are 20 amino acids in the standard genetic code. A Rice University professor wants to know what one can do with 21.

27 Sep 2019

Most breast cancer cases could be prevented by simple lifestyle modifications

Expert reports estimate that one in three breast cancer cases could be prevented by lifestyle modifications. Those modifications include such basics as weight management, physical activity, nutrition, and alcohol consumption, among others.

24 Sep 2019

UTHealth's innovative cancer-fighting projects receive $11 million CPRIT funding

Five innovative cancer-fighting projects at The University of Texas Health Science Center at Houston received just over $11 million during the latest round of grants awarded by the Cancer Prevention and Research Institute of Texas

21 Sep 2019

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.

19 Sep 2019

UT Southwestern researchers identify novel mechanism that regulates fat formation

In work suggesting new therapeutic targets to fight obesity, UT Southwestern researchers have identified a novel mechanism that regulates the creation of fat in mammals.

18 Sep 2019

Clinical trial finds no difference in pain response between SBRT and cEBRT for patients with spinal metastases

A Phase III, NRG Oncology clinical trial that compared radiosurgery or stereotactic body radiotherapy to the conventional radiotherapy for patients with spinal metastases indicated that there was no statistically significant difference between the treatments for pain response, adverse events, FACT-G, BPI, and EQ-5D scores.

17 Sep 2019

Study: Most U.S. adults are unaware that HPV causes anal, penile, and oral cancers

More than 70% of U.S. adults are unaware that human papillomavirus causes anal, penile, and oral cancers, according to an analysis led by researchers at The University of Texas Health Science Center at Houston School of Public Health and published in the current issue of JAMA Pediatrics.

16 Sep 2019

KU Cancer Center awarded grant to expand reach of clinical trials to Kansas’ rural communities

The University of Kansas Cancer Center and Midwest Cancer Alliance have been awarded a grant to expand the reach of cancer clinical trials to Kansas' rural communities.

10 Sep 2019

Lung-MAP study: Majority of cancer patients don't understand genomic test results

A majority of cancer patients don't understand key aspects of the genomic test results they receive as participants in biomarker-driven clinical trials, according to a first-of-its-kind pilot study conducted under the Lung Cancer Master Protocol.

10 Sep 2019

Cancer patients with low income and no insurance see fewer trial benefits

When it comes to benefiting from experimental treatments offered in cancer clinical trials, your health insurance status and where you live matters, according to results of two new research studies to be presented at the 2019 ASCO Quality Care Symposium, held September 6 and 7 in San Diego.

5 Sep 2019

UTA receives CPRIT funding to support cancer research programs

The University of Texas at Arlington received more than $2.1 million in grants from the Cancer Prevention & Research Institute of Texas to support the University's flourishing cancer research programs.

28 Aug 2019